Fixed-dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2
figureposted on 2020-03-09, 09:44 authored by Sanjay Asrani, Jason Bacharach, Edward Holland, Hayley McKee, Huan Sheng, Richard A. Lewis, Casey C. Kopczynski, Theresa Heah
Article full text
The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.
The above summary slide and plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.